Cellectar Biosciences, Inc. (CLRB) DCF Valuation

Cellectar Biosciences, Inc. (CLRB) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Cellectar Biosciences, Inc. (CLRB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our Cellectar Biosciences, Inc. (CLRB) DCF Calculator empowers you to evaluate Cellectar Biosciences' valuation using real-world financial data, offering complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -13.9 -15.1 -24.0 -28.7 -38.8 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 .2 .2 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -14.1 -15.4 -24.2 -28.9 -39.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 10.6 57.2 35.7 19.9 9.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.3 1.4 1.4 2.6 5.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 -.1 -.2 -.9 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0.15771 0.15771 0.15771 0.15771 0.15771 0.15771 0.15771 0.15771 0.15771 0.15771
EBITAT -13.9 -15.0 -24.1 -28.8 -38.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -12.4 -14.7 -24.0 -27.7 -36.5 -5.6 .0 .0 .0 .0
WACC, % 8.59 8.58 8.59 8.59 8.59 8.59 8.59 8.59 8.59 8.59
PV UFCF
SUM PV UFCF -5.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -5
Net Debt -9
Equity Value 4
Diluted Shares Outstanding, MM 12
Equity Value Per Share 0.31

What You Will Get

  • Pre-Filled Financial Model: Cellectar Biosciences' actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Instant Calculations: Automatic updates provide immediate results as you make adjustments.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for flexibility, enabling repeated use for in-depth forecasts.

Key Features

  • Customizable Research Parameters: Adjust essential factors such as clinical trial timelines, revenue projections, and R&D investments.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional financial metrics.
  • High-Precision Accuracy: Incorporates Cellectar Biosciences, Inc.'s (CLRB) actual financial data for credible valuation results.
  • Effortless Scenario Analysis: Easily explore various hypotheses and assess different outcomes.
  • Efficiency Booster: Avoid the complexities of developing intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Cellectar Biosciences data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Cellectar Biosciences’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Cellectar Biosciences, Inc. (CLRB)?

  • Designed for Experts: A sophisticated tool tailored for researchers, investors, and financial analysts.
  • Current Market Data: Cellectar's historical and projected financial information preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Clear, step-by-step guidance to navigate through the calculations.

Who Should Use This Product?

  • Investors: Accurately estimate Cellectar Biosciences, Inc.'s (CLRB) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Cellectar Biosciences, Inc. (CLRB).
  • Consultants: Quickly customize the template for valuation reports tailored to Cellectar Biosciences, Inc. (CLRB) clients.
  • Entrepreneurs: Discover insights into financial modeling practices used by leading biotech firms like Cellectar Biosciences, Inc. (CLRB).
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies relevant to Cellectar Biosciences, Inc. (CLRB).

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Cellectar Biosciences, Inc. (CLRB).
  • Real-World Data: Cellectar Biosciences’ historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios for Cellectar Biosciences, Inc. (CLRB).
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into Cellectar Biosciences, Inc. (CLRB).
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Cellectar Biosciences, Inc. (CLRB).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding Cellectar Biosciences, Inc. (CLRB).

No products were found matching.